您现在的位置是:Neuralink was reportedly denied FDA authorization to start human trials >>正文
Neuralink was reportedly denied FDA authorization to start human trials
上海品茶网 - 夜上海最新论坛社区 - 上海千花论坛294人已围观
简介By subscribing, you agree to our Terms of Use and Policies You may unsubscribe at any time.During Ne...
By subscribing, you agree to our Terms of Use and Policies You may unsubscribe at any time.
During Neuralink's first full unveiling presentation in 2019, founder Elon Musk claimed the company would one day insert computer chips into people's brains to fight diseases and mitigate the existential threat of AI.
It would always be a long-term development process, but Musk said at the time the company hoped to test its chip in humans before the end of 2020.
Almost four years later, the FDA has reportedly denied Neuralink authorization to conduct human trials using its brain-computer interface (BCI) devices. The main reason is that it has killed numerous animals during trials, as per a Reutersreport.
Neuralink denied authorization to go to human trials
Neuralink was reportedly denied FDA authorization to conduct human trials in 2022 in the same year that reports emerged the company had violated animal welfare and allegedly killed thousands of animals.
See Also"The agency’s major safety concerns involved the device’s lithium battery; the potential for the implant’s tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue," current and former Neuralink employees told Reuters.
According to the Reutersreport, the FDA is seeking reassurances about the BCI company's battery system, which uses novel transdermal charging capabilities. This is because a battery failure could cause a surge of electrical current or heat that could lead to severe irreparable brain damage.
The FDA is also concerned with the damage the device could cause during a removal procedure. This is mainly due to the tiny electrical leads inserted into a patient's (or user's) grey matter. Those electrical leads are so small that the FDA fears they could break during removal, migrate to other brain parts, and cause damage.
Neuralink employees reportedly call out Elon Musk's behavior
Musk's predictions about when Neuralink will test its hardware on humans are aging about, as well as his estimations for when the Tesla Cybertruck might finally enter production.
Critics have also compared Musk's statement that Neuralink's product was ready for human trials to his false claim that Tesla was close to achieving Level 5 autonomy — a leaked memo from Tesla employees called this claim an exaggeration.
In this light, the latest report comes across as a savage indictment of Musk's penchant for overemphasizing his company's achievements, even when lives might be on the line: "He can't appreciate that this is not a car," one Neuralink employee reportedly told Reuters. "This is a person's brain. This is not a toy."
Source: Reuters
Tags:
转载:欢迎各位朋友分享到网络,但转载请说明文章出处“上海品茶网 - 夜上海最新论坛社区 - 上海千花论坛”。http://www.jz08.com.cn/news/8996.html
相关文章
LayerZero and Delegate launch Clusters, a multichain naming protocol
Neuralink was reportedly denied FDA authorization to start human trialsLayerZero announced its LayerZero V2 upgrade three days ago with enhanced cross-chain interoperabili...
阅读更多
Tezos (XTZ) price rallies after the revelation of Ubisoft launching NFTs on Tezos network
Neuralink was reportedly denied FDA authorization to start human trialsAfter the morning announcement that Ubisoft will become the first major video game publisher to crea...
阅读更多
Bank Indonesia to Enforce Ban on Crypto Payments
Neuralink was reportedly denied FDA authorization to start human trialsThe country will also not allow crypto use in other unspecified financial services.Bank Indonesia ha...
阅读更多
热门文章
最新文章
POOCOIN, a stable BSC token: Where to buy POOCOIN
Celsius Price Analysis: Is CEL a good investment?
FTX US agrees deal with MSE establishing presence in Washington DC
BNB Chain to drive DeFi, gaming and AI adoption in 2024
Listen to Slant’s 25 Best Singles of 2014
Where to buy AquaGoat as price rallies by 25%